The neuropeptide galanin increases food intake. Chronic ethanol (EtOH) increases the expression of galanin in the hypothalamus. The research presented here examines the effects of microinjection of galanin in the third ventricle on voluntary alcohol intake.
A LCOHOLISM, ALSO KNOWN as alcohol dependence, is a disease that results from chronic consumption of high levels of ethanol-containing beverages sufficient to produce craving for alcohol and loss of control over drinking alcoholic beverages, often resulting in physical dependence on alcohol and tolerance to its behavioral and physiological effects (American Psychiatric Association, 2000) . These effects are common to all who consume excess amounts of EtOH over many years; however, the tendency to drink or experience the adverse consequences of EtOH varies depending on many factors such as ethnic background (both genetic and nongenetic factors) and social and economic levels (National Institute on Alcohol Abuse and Alcoholism, 1997) . The heterogeneity of alcoholdependent individuals suggests that there may be multiple neurobiological mechanisms that play a major role in the abuse of alcohol (Li, 2000; Li et al., 1991) .
Although there has been significant progress in the understanding of several of the neurochemical systems that mediate some of the reinforcing effects of EtOH, it is clear that the mechanisms are complex and involve many systems. Research indicates that alcohol reinforcement involves in part dopamine (DA), endogenous opioid (EO), and ␥-aminobutyric acid (GABA) systems, all of which have been implicated in reinforcement of other drugs of abuse (for reviews see Koob, 1998; Lewis, 1996) . However, the involvement of basic neurochemical systems for ingestive behavior in alcohol dependence is less clear. Other investigators (e.g., Samson and Hodge, 1996; Wise, 1997) have observed the importance of dysregulation of ingestive behavior in drug and alcohol dependence. Lewis (1996) suggested that EtOH, which is a rich source of calories, may interact with brain motivational systems that mediate appetite and food intake and that this may be particularly true in alcohol-dependent individuals. This interaction may be particularly important because brain and peripheral systems (e.g., liver, pancreas, stomach) that are essential for feeding and the utilization of nutrients deteriorate as a result of the chronic exposure to EtOH (Lieber, 1988 (Lieber, , 1991 . Under such circumstances, EtOH, because of its nutritional value and/or its effects on central and peripheral nutritional mechanisms, could have enhanced reinforcing properties that increase alcohol abuse.
There are many observations that suggest an interrelationship between alcohol consumption and food consumption. Alcoholic beverages increase food intake, with certain beverages serving as an aperitif. Food deprivation increases not only feeding but also alcohol intake (Meisch, 1977) . Furthermore, researchers have used sweet tastes to facilitate alcohol self-administration in the laboratory (Samson, 1986) .
One approach to understand this interrelationship is to manipulate neuropeptide systems that are known to control food intake to determine their effect on EtOH intake. This has been used successfully with neuropeptide Y (NPY) (Katner et al., 2002; Thiele et al., 2003) , corticotropin releasing factor (CRF) (Koob, 1998) , and EO (Gianoulakis, 2004) . Galanin is one of several neuropeptides that can increase food intake (Crawley et al., 1990; Leibowitz and Hoebel, 2004) . Injection of galanin into the third ventricle, the paraventricular nucleus (PVN), or the nucleus of the solitary tract increases food intake (for review see Crawley, 1999; Leibowitz and Hoebel, 2004) . Central galanin increases the consumption of a fat-rich diet and somewhat less the consumption of carbohydrates (Leibowitz, 1991; Tempel et al., 1988) . Conversely, the consumption of fats can increase the expression of galanin in hypothalamic nuclei (Akabayashi et al., 1994; Leibowitz et al., 1998) . The effects of galanin also seem to have a diurnal aspect, because the effects are more pronounced during the latter portion of the dark (Tempel and Leibowitz, 1990) , although they are also seen during the light period (Smith et al., 1994) .
Recent findings indicate that galanin may be involved in alcohol consumption and the motivation to drink alcohol beverages. Chronic administration of EtOH increased the expression of galanin in hypothalamic nuclei, including the PVN . Moreover, injection of galanin into the PVN can release DA in the nucleus accumbens (Rada et al., 1998) . The research presented here examines the effects of injection of galanin into the third ventricle on voluntary alcohol intake of 7% EtOH during both light and dark conditions. Some of this work was published as an abstract (Lewis et al., 2003) .
MATERIALS AND METHODS

Subjects and Home Cage Conditions
Male Sprague Dawley rats that were bred at the Princeton University Department of Psychology animal facility from stock that originated from Taconic Farms (Germantown, NY) served as subjects. Each weighed between 280 and 300 g at the beginning of experimentation and was individually housed in a large cage [18.5 (width) ϫ 25.2 (length) ϫ 10.5 (height) cm]. They were maintained on 12:12-hr light-dark cycle with the lights off at 6:00 AM. Water was always available either from an automated system or in the two-bottle EtOH-water choice described below. Laboratory food was available ad libitum in the home cage for all experiments.
Surgery
An outer guide cannula (22-G stainless steel) directed to 1 mm above the third ventricle (coordinates: AP Ϫ2.3; ML 0.0; DV Ϫ7.5 from bregma, midsagittal sinus, and level skull, respectively) was surgically implanted in 14 rats. Surgery was performed under anesthesia induced by xylazine (10 mg/kg, intraperitoneally) supplemented with ketamine (80 mg/kg, intraperitoneally). For microinjection, an inner cannula (26-G stainless steel) that protruded 1 mm beyond the guide cannula to reach the third ventricle was inserted.
Acquisition of Oral EtOH Intake
To determine the effects of galanin on EtOH intake, we used a twobottle choice procedure. This choice paradigm has been used successfully to investigate EtOH-seeking behavior and the selective breeding of animals with EtOH preference (Li et al., 1991) . The use of two-bottle choices of varying concentrations of EtOH from 0 to 10% has recently been shown to exhibit the same basic properties as other stimuli that function as reinforcers in randomly bred (Martinetti et al., 2000) and alcoholpreferring P rats (Martinetti and Lewis, 2004) .
Seven to 11 days after surgery, all animals were presented with a choice of EtOH and water in the home cages for 12 hr/day starting at 10:00 AM. Fluid intake was measured with two sets of graduated cylinders permitting measurement of ethanol to the nearest milliliter during the dark portion of the light-dark cycle and to the nearest 0.1 ml during the light. The concentration of EtOH increased from 1, 2, 4, to 7% (v/v) with the concentration increasing each time an animal acquired a preference 2 days in a row for the EtOH solution over water (every 3-5 days). All animals consistently drank more 7% EtOH than water at the end of training. The 7% EtOH versus water choice for 12 hr/day was used for comparison with previous research using this regimen (e.g., Avena et al., 2004) .
Microinjection
Microinjection began 1 week after stable oral intake in the following sequence with Ringer given 1 day before each drug test: 1 and 3 nmol of galanin, 1 nmol of M40 (galanin antagonist), and 3 nmol of galanin combined with 1 nmol of M40. Tests were separated by at least 3 days. Galanin and M40 were purchased from American Peptide Co., Inc. (Sunnyvale, CA). Drugs were dissolved in Ringer solution and prepared immediately before microinjection. For the combination of the agonist and the antagonist, M40 was injected followed by the injection of galanin 5 to 10 min later. Animals were given the choice of EtOH and water 5 to 12 min after the injections. Injection volumes of 0.5 to 1.0 l were injected for 60 sec with the inner cannula remaining in place for an additional 30 sec. The effects of galanin were initially tested during the dark portion of the light-dark cycle in 14 rats and then during the light in 12 of these rats that still had a patent cannula.
Testing Procedures
EtOH versus water during the dark After the 2-to 3-week period of acquisition training described above, all animals (n ϭ 14) were given a choice between EtOH and water in their home cages with the bottles placed on the cages for 12 hr starting between 10:00 and 11:00 AM, which was 4 to 5 hr after the lights went out. Intake was measured 1, 3, and 12 hr after placement of the bottles. The rats remained on this schedule for an additional 3 to 4 weeks for baseline intake measurement and the sequence of microinjections as described above. The total period of EtOH access during the dark was~6 weeks.
Food intake during the dark For examining the effects of galanin on food intake while rats had access to EtOH, food was weighed to the nearest 0.5 g at the start and end of the access period in a subset (n ϭ 6) of the animals during EtOH and water choice testing in the dark as described above. Laboratory food pellets were made available in open containers from 11:00 AM until 4:00 PM.
EtOH versus water during the light After the completion of experiments during the dark portion of the daily cycle, EtOH and water were presented during the light period. Bottles were placed on the cages at 8:00 PM, and intake was measured 1, 3, and 12 hr later. Microinjections began after all rats (n ϭ 12) showed stable consumption (1 week). Total testing time during the light was~6 weeks.
Histology
At the completion of experimentation, 8 of the 14 animals were killed and brains were dissected to examine the location of the tip of the inner cannula. Blue ink (0.5 l) was injected through the cannula in four animals to enhance further the examination of the microinjection site.
Data Analysis
A priori planned comparisons of the effects of galanin or the galanin antagonist M40 with the respective vehicle control were performed for the 1-and 3-hr time periods using correlated Student's t test for both light and dark periods. This method of analysis permitted the comparison of each dose and compound with the preceding vehicle control. To reduce the probability of type 1 error, the ␣ used for these tests was 0.02 (two-tailed distribution). A posteriori comparisons of other mean differences were performed using Student's t test with ␣ adjusted using the Bonferroni procedure (Winer et al., 1991) . A single factor repeated measures ANOVA was performed on food intake for a posteriori analysis of these data.
RESULTS
Voluntary EtOH Intake
All of the animals developed a clear preference for 7% EtOH over water by the end of acquisition training. Figure  1 shows that the preference was pronounced at 1 hr and increased further at the 3-hr reading. Mean consumption of the 7% EtOH was 2.2 g/kg during the 12-hr period of access for nondrug trials before drug infusion. Consumption during the first hour ranged from 0.5 to 1.0 g/kg.
Effects During the Dark
Microinjection of galanin into the third ventricle during the dark produced a significant increase in consumption of the 7% EtOH solution. Figure 2 , top left, shows that there was an increase with both the 1-and 3-nmol microinjections during the first hour (t ϭ 3.16, df ϭ 13, p Ͻ 0.01; and t ϭ 3.00, df ϭ 13, p Ͻ 0.02, respectively). At the 1-hr time period, EtOH intake with the 3-nmol dose was greater than that of the 1-nmol dose (t ϭ 2.65, df ϭ 7, p ϭ 0.01), and both doses had effects greater than Ringer. At 3 hr, only the 3-nmol dose produced a significantly greater response than Ringer vehicle (t ϭ 2.93, df ϭ 7, p Ͻ 0.02). Galanin did not affect water consumption at either dose (Fig. 2, bottom left) .
As seen in Fig. 2 , right, the antagonist M40 administered with 3 nmol of galanin blocked the increase in consumption relative to Ringer vehicle at both the 1-and 3-hr time points (t ϭ 0.69, df ϭ 7, p ϭ 0.51; and t ϭ 0.26, df ϭ 7, p ϭ 0.89, respectively). M40 alone produced a small but significant decrease in consumption at 1 hr (t ϭ 2.67, df ϭ 7, p Ͻ 0.04) but not at the 3-hr time point (t ϭ 0.26, df ϭ 7, p ϭ 0.80).
Effects on Food Intake
In the separate test of microinjection of galanin during the dark with measurement of both food and EtOH, there was no effect on food intake in the 5 hr after injection [F(5,25) ϭ 0.78, p Ͼ 0.05]. It was anticipated that galanin might increase food intake during this period; however, as can be seen in Fig. 3 , there were no effects of either the 1-or 3-nmol dose on food intake in these rats that had learned to drink EtOH and in which galanin increased EtOH intake.
Effects During the Light Period
Microinjection of galanin into the third ventricle during the light again increased the consumption of EtOH. Figure  4 , top left, shows that both the 1-and 3-nmol doses significantly increased voluntary intake compared with Ringer during the first hour (t ϭ 4.05, df ϭ 11, p Ͻ 0.01; and t ϭ 4.82, df ϭ 11, p Ͻ 0.01, respectively). This larger increment in ethanol intake occurred during a period when the animals normally drank virtually nothing (as seen with the vehicle condition). The effect was also evident at the third hour (t ϭ 5.18, df ϭ 10, p Ͻ 0.01; and t ϭ 2.97, df ϭ 10, p Ͻ 0.01, respectively). The 3-nmol dose produced a somewhat larger increase in EtOH intake than the 1-nmol dose at both time points; however, this difference was not significant (t ϭ 0.45, df ϭ 10, p ϭ 0.66 at 1 hr; t ϭ 0.03, df ϭ 10, p ϭ 0.97 at 3 hr). As shown in Fig. 3 , bottom, galanin did not have any effect on water consumption at any time point.
The effects of galanin on EtOH intake were again completely blocked by the galanin antagonist M40 (Fig. 2, top  right) . The combination of 3 nmol of galanin and M40 was not different from the vehicle control at 1 hr (t ϭ 0.89, df ϭ 9, p Ͼ 0.05). As with galanin alone, neither M40 ϩ 3 nmol of galanin nor M40 alone had any effects on water consumption during this time (Fig. 2, bottom right) . 
Site of Microinjection
The inner cannula tips were within the third ventricle for the eight animals examined. Sites were between coronal 2.3 and 2.8 mm of the rat brain atlas of Paxinos and Watson (1998) .
DISCUSSION
The data presented here show that third-ventricle microinjection of galanin can increase voluntary intake of 7% EtOH intake with no effect on water intake. The incremental effect was more pronounced during the light, when the animals are inactive and normally drink very little. The effects of galanin seem to be dose dependent, with the 3-nmol dose producing a larger increase of EtOH intake than the 1-nmol dose in the dark period. The selective galanin receptor antagonist M40 completely blocked the galanin-induced increases in alcohol intake in both the light and the dark periods. Moreover, M40 alone may reduce alcohol consumption slightly, without suppressing water intake, as seen with M40 alone at the 1-hr time point during the dark. This effect could not be seen during the light because of the low basal level of intake of EtOH during that period (Fig. 4) .
The present findings are in agreement with recent data (Rada et al., 2004) showing that direct injection of galanin into the PVN increases the consumption of EtOH in tests with 4% EtOH. It is likely that galanin injected into the third ventricle in the present experiment reached the receptive sites in the PVN. It is also possible that galanin reached other sites near the third ventricle, where it has been shown to increase food intake [e.g., dorsomedial nucleus and ventromedial nucleus (Crawley, 1999) ] and where it might increase EtOH intake as well. The suppression of EtOH intake by the microinjection of M40 is also consistent with Rada et al. (2004) and suggests that blockade of endogenous galanin receptors decreases EtOH intake.
The present data show that galanin increases consumption of alcohol during the light period, when they normally consume little, if anything. It seems that rats that have been chronically consuming EtOH in the dark, active period show a tendency to voluntarily consume it under the influence of galanin even when they are usually inactive. It is interesting to note that alcoholics frequently exhibit sleep disturbances (for review, see Ehlers, 2000; Rohrs and Roth, 2001) , as do rats that are chronically administered alcohol (Ehlers and Slawecki, 2000) . Insomnia in alcoholics is frequently associated with drinking during the evening and nighttime (Brower et al., 2001) .
The effect of galanin seems to be specific to EtOH intake, given the lack of effect on food and water intake. Although we did not observe an increase in food intake over a 5-hr period, it is possible that galanin did produce an increase in the first hour or two. However, most research with similar doses of galanin show increases in food intake that are evident 5 hr after injection. For example, Leibowitz (1991) found that low doses of galanin increase fat consumption for 24 hr, and Smith et al. (1994) showed that 300 pmol of galanin intracerebroventricularly increased cumulative food consumption over 4 hr. Although further experimentation is necessary on this point, the present data show that galanin did not increase food intake in rats that had been chronically consuming EtOH. This suggests that the animals in this experiment were not consuming EtOH just for its calories. If confirmed, then the data would support the hypothesis (Lewis, 1996) that chronic exposure to EtOH will alter mechanisms that regulate nutrition and the motivation to consume nutrients. In rats that are trained to chronically drink EtOH, galanin seems to stimulate the appetite for alcohol. It remains to be determined whether this enhancement is selective for EtOH over other preferred substances. Several other neuropeptides that influence feeding have been shown to affect EtOH intake, including CRF (Koob, 1998) , NPY (Thiele et al., 2003) , and EO (Gianoulakis, 2004) . CRF is an inhibitor of both food and alcohol intake (Thiele et al., 2003) . NPY's effect on EtOH intake is more complex. Intracerebroventricular injection of NPY produces no effects on EtOH intake in alcohol-preferring AA rat, but it reduces intake in alcohol-preferring P rats (Badia-Elder et al., 2001) . In contrast, direct injection of NPY into the PVN increases EtOH consumption in randomly bred rats (Kelley et al., 2001) . NPY is a potent stimulator of food intake, especially carbohydrates. Galanin is a potent stimulator of food intake also; however, it has a more potent effect on consumption of fat-rich diets (Tempel and Leibowitz, 1990) . Certain opioids increase both food and EtOH intake in some circumstances. EO biosynthesis and release, expression, and receptor activity are influenced by EtOH administration (Gianoukakis, 2004; Herz, 1997) . Low doses of a systemic (Hubbell et al., 1986) or central (Linseman and Harding, 1990 ) opioid agonist increases EtOH consumption. Conversely, opioid antagonists given systemically (Hubbell et al., 1986) or centrally (Heyser et al., 1999) decrease EtOH selfadministration. It is interesting that galanin's stimulatory effect on feeding can be blocked by the opioid antagonist naloxone (Dube et al., 1994) . The mechanisms by which the EO neuropeptides and galanin interact to regulate food intake is yet to be determined; however, it may be that the same mechanisms also influence alcohol consumption.
The interaction of alcohol with food intake has long been known. Beverages that contain EtOH are used as an aperitif, and alcohol has been shown to increase food intake in rodents (Hetherington et al., 2001; Meisch, 1977; Yeomans et al., 2003) . Alcohol-dependent individuals consume a substantial proportion of their total dietary caloric intake as alcohol. It is not uncommon for severely dependent alcoholics to consume 30 to 50% of their daily calories as EtOH (Lieber, 1988; Mitchell and Herlong, 1986) . A prominent aspect of alcohol dependence is severe disturbances in food intake, especially the intake, metabolism, and storage of lipids (see Lieber, 1991, for review) . The relation of galanin to the consumption and metabolism of dietary fat has been shown by several lines of research (see Leibowitz and Hoebel, 2003, for review) .
The present data showing that intracerebroventricular galanin can increase EtOH intake, combined with that of Rada et al. (2004) showing an increase in EtOH intake with PVN injection and Leibowitz et al. (2003) showing that EtOH intake augments galanin mRNA expression, together suggest that chronic EtOH intake may result in a positive feedback loop between galanin release and EtOH intake. Thus, alcohol stimulates galanin production, and galanin can induce alcohol intake. It may be that in some alcohol-dependent individuals, EtOH leads to increased galanin activation that then motivates further intake of EtOH at the expense of nutritious food. Such a mechanism could conceivably play a role in certain forms of alcohol dependence.
